Skip to main content
Skip to main content
TMPMU logo

Turmeric Acquisition Corp. (TMPMU) Stock Analysis

DELISTED 2022

What happened to Turmeric Acquisition Corp. (TMPMU) stock?

Turmeric Acquisition Corp. (TMPMU) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.

Vol: 2.2K| 52-wk range: $9.85 – $10.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Turmeric Acquisition Corp. (TMPMU) trades at $9.99. Turmeric Acquisition Corp. is a shell company focused on merging with or acquiring a business in the healthcare or related industries. Sector: Financial services.

Last analyzed: Mar 18, 2026
Turmeric Acquisition Corp. is a shell company focused on merging with or acquiring a business in the healthcare or related industries. Founded in 2020, it is based in Cambridge, Massachusetts, and is a subsidiary of Turmeric Management, LLC.

Analyst Coverage for TMPMU: TMPMU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TMPMU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the TMPMU film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 55/100 · B

TMPMU: 1/2 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bullish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Turmeric Acquisition Corp. (TMPMU) Financial Services Profile

HeadquartersCambridge, US
IPO Year2020

Turmeric Acquisition Corp., a shell company incorporated in 2020, seeks a merger, acquisition, or similar business combination within the healthcare sector. Based in Cambridge, MA, the company offers investors exposure to potential healthcare industry growth through its future target acquisition, operating as a subsidiary of Turmeric Management, LLC.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for TMPMU?

As of Mar 18, 2026 — figures reflect the data available on that date.

Turmeric Acquisition Corp. presents a speculative investment opportunity centered on its ability to identify and successfully merge with or acquire a promising healthcare business. The investment thesis hinges on the management team's expertise in the healthcare sector and their ability to navigate the complex landscape of potential target companies. Key value drivers include the identification of a high-growth target with strong fundamentals, successful negotiation of a merger agreement, and positive market reception to the combined entity. However, the investment is subject to significant risks, including the failure to find a suitable target, regulatory hurdles, and market volatility. With a P/E ratio of 18.97 as of 2026-03-18, the company's valuation is dependent on future performance following a potential acquisition. The absence of a dividend further emphasizes the speculative nature of the investment, relying solely on capital appreciation.

Based on FMP financials and quantitative analysis

TMPMU Key Highlights

Turmeric Acquisition Corp. focuses on healthcare or a healthcare related industry.

  • The company was incorporated in 2020 and is based in Cambridge, Massachusetts.
  • Turmeric Acquisition Corp. is a subsidiary of Turmeric Management, LLC.
  • The company's P/E ratio is 18.97 as of 2026-03-18.
  • Turmeric Acquisition Corp. does not offer a dividend.

Who Are TMPMU's Competitors?

TMPMU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ACAH Atlantic Coastal Acquisition Corp. $10.45 -1.69% $127M 44
BMAC Black Mountain Acquisition Corp. $10.56 -0.38% $131M 44
DTI Drilling Tools International Corp. $2.64 +3.53% $92.8M 34
KCGI Kensington Capital Acquisition Corp. V $11.17 +0.09% $128M 44
LFAC Leapfrog Acquisition Corporation $10.07 +0.25% $193M 64
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TMPMU's Key Strengths?

Experienced management team with healthcare expertise

  • Access to capital through public markets
  • Focus on a high-growth industry (healthcare)
  • Flexibility to pursue a variety of transaction structures

What Are TMPMU's Weaknesses?

Lack of operating history

  • Dependence on identifying and acquiring a suitable target
  • Competition from other SPACs
  • Potential for dilution of shareholder value

What Could Drive TMPMU Stock Higher?

Announcement of a definitive merger agreement with a target company.

  • Completion of the merger or acquisition transaction.
  • Positive market reception to the combined entity.
  • Achievement of key milestones by the acquired company.
  • Favorable developments in the healthcare industry.

What Are the Key Risks for TMPMU?

Failure to identify and acquire a suitable target company.

  • Regulatory hurdles and delays.
  • Market volatility and economic uncertainty.
  • Competition from other SPACs.
  • Dilution of shareholder value.

What Are the Growth Opportunities for TMPMU?

  • Successful Acquisition: Turmeric Acquisition Corp.'s primary growth opportunity lies in successfully identifying and acquiring a high-growth healthcare company. By merging with a disruptive player in areas like telehealth, personalized medicine, or medical devices, Turmeric Acquisition Corp. could unlock significant value for its shareholders. The timeline for this growth opportunity is dependent on the company's ability to find a suitable target and complete the acquisition process, which could take several months to a year.
  • Operational Improvements: Following a successful acquisition, Turmeric Acquisition Corp. can drive growth by implementing operational improvements within the acquired company. This could involve streamlining processes, reducing costs, expanding into new markets, or launching new products and services. The potential for operational improvements will vary depending on the specific target company, but it represents a significant opportunity to enhance profitability and accelerate growth. The timeline for realizing these improvements is typically one to three years after the acquisition.
  • Synergies and Integration: A merger can create synergies between the SPAC and the target company, leading to cost savings and revenue enhancements. Integrating the target company's operations, technology, and customer base can unlock significant value. For example, the combined entity might be able to cross-sell products or services to a larger customer base or leverage shared resources to reduce expenses. The timeline for realizing these synergies is typically one to two years after the acquisition.
  • Market Expansion: The acquired healthcare company may have opportunities to expand into new geographic markets or customer segments. Turmeric Acquisition Corp. can provide the capital and expertise to support this expansion, driving revenue growth and increasing market share. The timeline for market expansion will depend on the specific opportunities available to the target company, but it could be a significant growth driver over the long term.
  • Innovation and New Product Development: Investing in research and development and launching new products and services can drive organic growth for the acquired healthcare company. Turmeric Acquisition Corp. can provide the funding and strategic guidance to support these innovation efforts, leading to new revenue streams and a stronger competitive position. The timeline for new product development can vary significantly, but it is a critical driver of long-term growth and value creation.

What Opportunities Does TMPMU Have?

  • Growing demand for healthcare services
  • Increasing innovation in the healthcare industry
  • Potential for consolidation in the healthcare market
  • Favorable regulatory environment for healthcare companies

What Are TMPMU's Competitive Advantages?

  • Management team's expertise in the healthcare sector
  • Access to capital through the public markets
  • Ability to identify and attract promising healthcare companies
  • Established network of industry contacts

What Does TMPMU Do?

Turmeric Acquisition Corp. (TMPMU) was established in 2020 with the explicit purpose of identifying and merging with, acquiring, or otherwise combining with one or more businesses or entities. The company's primary focus is on targeting opportunities within the healthcare industry or sectors closely related to healthcare. As a special purpose acquisition company (SPAC), Turmeric Acquisition Corp. does not have significant operational activities of its own. Instead, it serves as a vehicle for investors to participate in a potential future business combination. The company is based in Cambridge, Massachusetts, and operates as a subsidiary of Turmeric Management, LLC. The success of Turmeric Acquisition Corp. hinges on its management team's ability to identify and execute a transaction with a promising healthcare-related business. The ultimate goal is to bring a private company public through the SPAC structure, offering investors exposure to the target company's future growth and potential value creation. The company's strategy involves rigorous due diligence and assessment of potential target companies to ensure alignment with its investment criteria and the potential for long-term value appreciation. Turmeric Acquisition Corp. represents an opportunity for investors to gain exposure to the healthcare sector through a unique investment vehicle.

What Products and Services Does TMPMU Offer?

  • Turmeric Acquisition Corp. is a special purpose acquisition company (SPAC).
  • It seeks to merge with or acquire a company in the healthcare industry.
  • The company does not have significant operations of its own.
  • It provides a vehicle for investors to participate in a potential future business combination.
  • The company's success depends on its ability to identify and execute a transaction with a promising healthcare-related business.
  • The company aims to bring a private company public through the SPAC structure.

How Does TMPMU Make Money?

  • Turmeric Acquisition Corp. raises capital through an initial public offering (IPO).
  • It uses the capital to search for a target company in the healthcare sector.
  • If a suitable target is found, Turmeric Acquisition Corp. merges with or acquires the target company.
  • The target company then becomes a publicly traded company.

What Industry Does TMPMU Operate In?

Turmeric Acquisition Corp. operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). The SPAC market has experienced significant growth in recent years, driven by the desire of private companies to go public more quickly and with less regulatory scrutiny than traditional IPOs. This industry is characterized by intense competition among SPACs seeking attractive target companies. The healthcare sector, which Turmeric Acquisition Corp. is targeting, is a large and growing market, but also highly competitive and regulated. The success of Turmeric Acquisition Corp. will depend on its ability to differentiate itself from other SPACs and identify a compelling target company in the healthcare space.

Who Are TMPMU's Key Customers?

  • Institutional investors
  • Retail investors
  • Hedge funds
  • Private equity firms
AI Confidence: 69% Updated: Mar 18, 2026

Company Profile

Turmeric Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Cambridge, US. TMPMU has traded publicly since 2020.

ROE 14%

Key Financial Metrics

Return on equity for Turmeric Acquisition Corp. stands at 13.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.8%, showing how much profit it generates from its asset base. A current ratio of 0.95 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

TMPMU Financials

Fundamental Snapshot

Return on Equity (TTM)
+13.8%
Current Ratio
1.0

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Market sentiment data being refreshed
  • Community discussions being analyzed

Bear Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Risk factors being evaluated
  • Market concerns being processed

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

TMPMU Latest News

No recent news available for TMPMU.

What Investors Ask About Turmeric Acquisition Corp. (TMPMU) — Financial Services

What happened to Turmeric Acquisition Corp. (TMPMU) stock?

Turmeric Acquisition Corp. (TMPMU) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.

Can I still buy TMPMU shares?

No. TMPMU stopped trading on public markets in October 2022, so the shares are not available through a broker. Anything you see quoted for TMPMU elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before TMPMU stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Turmeric Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Turmeric Acquisition Corp. do?

Turmeric Acquisition Corp. is a special purpose acquisition company (SPAC) that was formed to acquire or merge with one or more businesses, with a focus on the healthcare sector. The company does not have any operating activities of its own. Its sole purpose is to identify a promising private healthcare company and bring it public through a merger.

What are the main risks for TMPMU?

The primary risk for Turmeric Acquisition Corp. is the failure to identify and acquire a suitable target company within the healthcare sector. If the company is unable to complete a transaction within a specified timeframe, it may be forced to liquidate, returning capital to shareholders but potentially resulting in lost opportunity costs.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on publicly available sources and is subject to change.
  • Investment in SPACs involves significant risks and is not suitable for all investors.
Data Sources

Popular Stocks

More Stocks We Cover